Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.036 | 0.9 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |